Wednesday, July 19, 2023

NIAID Funding News, July 19, 2023

NIH/NIAID Template Banner

July 19, 2023 NIAID Funding News

Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news/2023-07-19

Feature Articles 

Grant Coming to an End? Avoid and Survive a Funding Gap

As long as you have accomplished enough to build a strong case for renewing your grant, apply early so you have time to revise and resubmit without risking an interruption in funding.

Opportunities and Resources

Help us advance and improve congenital and adult acquired syphilis research. We encourage translational diagnostic development research including the collection and use of clinical samples.

Propose basic, preclinical, or clinical research studies using existing human samples to analyze and compare HIV reservoir establishment, dynamics, persistence, and post-treatment control among different HIV subtypes and in diverse cohorts of people living with HIV.

Aim to build on recent breakthroughs in biology of mucosal systems, biology and immunology of mucosal infection, and microbiome research.

Plan to target mechanisms that are integral for the replication, growth, survival, or virulence of a pathogen, including toxins or toxin-related targets as novel anti-infectives.

In The News

The virtual tour lets visitors from around the world learn about NIH's mission, research, labs, and facilities by showcasing 20 in-depth tour stops on NIH's campus. 

NIH's Continuous Submission Policy allows appointed members of review and advisory groups to submit applications to certain notices of funding opportunities after the standard deadline.

Advice Corner

To be eligible, you must be a doctoral-level clinician or researcher who is committed to conducting NIH-relevant research at a domestic, non-profit, or government organization.

Reader Questions

New Funding Opportunities

  • NOT-AI-23-044, Notice of Special Interest (NOSI)—Administrative Supplement for Collaborative Projects Supported by the NIAID/RNCP

  • PAR-23-219, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late-Stage Development (SB1, Clinical Trial Not Allowed)

  • PA-23-230, PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44], Clinical Trial Not Allowed)

  • PA-23-232, PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42], Clinical Trial Not Allowed)

Find other announcements at NIAID Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment

UX Design Weekly: Confirm Your Subscription

    IMPORTANT: To ensure yo...